phone image +91 22 68948500, 68948500

 

IPO Synopsis

Rossari Biotech Ltd
  • Registered Office: 201 A-B 2nd Floor LBS Marg,Akruti Corporate Park Kanjur(W, Mumbai - 400079, Maharashtra, India. Phone : 91-22-6123 3800   Fax:91-22-2579 6982
  • Email : cs@rossarimail.com
  • Website :www.rossari.com
Initial Public Offering of 11,676,470 equity shares of face value of Rs. 2 each ("equity shares") of Rossari Biotech Limited (the "company" or the "issuer") for cash at a price of Rs. 425 per equity share (including a share premium of Rs. 423 per equity share) (the "offer price") aggregating to Rs. 496.25 Crores comprising a fresh issue of 1,176,470 equity shares aggregating to Rs. 50* Crores (the "fresh issue") and an offer for sale of 10,500,000 equity shares (the "offered shares") aggregating to Rs. 44.63 Crores, comprising an offer for sale of 5,250,000 equity shares aggregating to Rs. 22.31 Crores by Mr. Edward Menezes and 5,250,000 equity shares aggregating to Rs. 22.31 Crores by Mr. Sunil Chari (the "promoter selling shareholders" or the "selling shareholders"), (the "offer for sale", and together with the fresh issue, the "offer"). The offer shall constitute 22.49% of the post-offer paid up equity share capital of the company. The company has, in consultation with the book running lead managers ("brlms"), undertaken a private placement of equity shares aggregating to Rs. 99.999 Crores ("pre-ipo placement"). The size of the fresh issue of up to Rs. 150 Crores has been reduced by Rs. 99.999 Crores pursuant to the pre-ipo placement and accordingly, the size of the fresh issue is up to Rs. 50. Crores
Issue
Opens On Closes On
13-Jul-20 15-Jul-20
Money Payable On
Application Allotment
425.00 0.00
Minimum Application for shares in Nos : 35 Further Multiples of : 35
RsCr Lead Managers to the Issue
Project Cost (Rs.Cr) 0.00 Axis Capital Ltd
Project Financed through Current Offer (Rs.Cr) 496.25  
Post Issue Equity Share Capital (Rs.Cr) 10.39
Issue Price (Rs) 425.00

Projects
Repayment/Prepayment of certain Indebtedness availed by the company (including accrued Interest)
Funding Working Capital Requirements
General Corporate Purposes
Promoted By
Edward Walter Menezes
Sunil Srinivasan Chari
Listing At
BSE
NSE
Registrar to the Issue
No Data Available
SEBI Single Regn. No. : BSE / NSE / MSMI - INZ000192537  |   CDSL Reg. No :  IN-DP-CDSL-438-2008                                                                                                                           Filing complaint on SEBI SCORES
Copyright © 2016 All rights reserved Comfort Securities Ltd.
Designed, Developed and content powered by CMOTS Infotech(ISO 9001:2015 certified)
Attention Investors ::
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investors account.   |    Kyc is one time exercise while dealing in securities markets:- Once KYC is done through a SEBI Registered Intermediary(Broker DP Mutual Fund etc.) you need not undergo the same process again when you approach another Intermediary.” “ Prevent Unauthorized Transaction in your Trading/Demat account. Update your Mobile Numbers/Email IDs with your Stock Broker/Depository Participant. Receive alerts/information of your transaction/all debit and other important transactions in your Trading/Demat account Directly from Exchange/CDSL at the end of the day. Issued in the Interest of Investors. 
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 2. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors